STSS - Sharps Technology Inc


0.0169
-0.003   -18.343%

Share volume: 76,008,008
Last Updated: 04-08-2025
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.03%

PREVIOUS CLOSE
CHG
CHG%

$0.02
0.00
-0.16%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
11%
Profitability 0%
Dept financing 17%
Liquidity 12%
Performance 20%
Company vs Stock growth
vs
Performance
5 Days
-34.50%
1 Month
-96.16%
3 Months
-99.18%
6 Months
-89.06%
1 Year
-94.88%
2 Year
-98.63%
Key data
Stock price
$0.02
P/E Ratio 
0.00
DAY RANGE
$0.01 - $0.02
EPS 
-$3.75
52 WEEK RANGE
$0.01 - $4.16
52 WEEK CHANGE
-$95.01
MARKET CAP 
3.703 M
YIELD 
N/A
SHARES OUTSTANDING 
28.591 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
04-15-2025
BETA 
1.08
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$127,932,250
AVERAGE 30 VOLUME 
$83,889,857
Company detail
CEO: Robert M. Hayes
Region: US
Website: sharpstechnology.com
Employees: 3
IPO year: 2022
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

Sharps Technology Inc. researches, designs, develops, manufactures, distributes, and sells safety syringe products. Sharps Provensa is an ultra-low waste space syringe for the administration of various vaccines and injectable medications. The company was incorporated in 2017 and is based in Melville, New York.

Recent news
loading